Valence ロゴ
人気
ログイン

ウォッチリストに追加
Proチャート

Drugs Made In America Acq...

NasdaqGM: DMII · リアルタイム株価 · USD
10.13
+0.00 (0.00%)
終値時点： Aug 12, 2026, 1:20 PM

Drugs Made In America Acquisition II Corp. (DMII) Stock Price, Analysis & Data

0.00%
買気配10.11
時価総額645.28M
売上高（TTM）n/a
純利益（TTM）8.58M
ベータn/a
EPS（TTM）0.13
PER（TTM）77.92
予想PERn/a
PBR（TTM）-36.18
PSR（TTM）n/a
Earnings Daten/a
売気配10.09
出来高30
平均出来高（20日）61,693
始値10.13
前日終値10.13
当日レンジ10.13 - 10.13
52週レンジ9.86 - 10.20
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

DMIIについて

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...

[続きを読む]
業種 Shell Companies
セクター Financial Services
IPO日 Dec 3, 2025
従業員数 n/a
上場取引所 NasdaqGM
ティッカー DMII
企業情報の全文

業績

2025年のDrugs Made In America Acquisition IIの売上高は0で、前年のn/aからundefined%の増加でした。 利益は4.19Mで、undefined%の増加でした。

財務諸表
news image

5か月前 · Motley Fool

NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave

MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and re...

news image

8か月前 · Simply Wall St.

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company

Key Insights Institutions' substantial holdings in Drugs Made In America Acquisition II implies that they have...